Stock Ticker

  • Loading stock data...

InVivo Therapeutics Promotes Brian Hess as CSO (NVIV)

InVivo Therapeutics (OTC: NVIV) has just announced that its director of product development, Brian Hess, will be taking over as the Chief Science Officer for the company. Hess joined InVivo just months before and will be taking over from Edward Wirth M.D., Ph.D. About InVivo InVivo Therapeutics is a developer of new technology pertaining to […]

Can New Science Officer Rejuvenate InVivo Therapeutics? (NVIV)

InVivo Therapeutics (OTC: NVIV)¬†announced an interim successor to fill the Chief Science Officer position recently vacated by Dr. Edward Wirth due to personal reasons. Brian Hess, a former product development specialist with Stryker (NYSE: SYK) and current product development manager for InVivo Therapeutics, will assume the role of Chief Science officer. Mr. Hess will take […]

InVivo Therapeutics Staggers over Recent Positive News (NVIV)

Two weeks ago, InVivo Therapeutics (OTC: NVIV) released second quarter financial results that showed a pro forma loss of $0.04 versus a loss $0.05 for the same period last year. The company also mentioned the clinical progress for its biopolymer scaffolding and hydrogel technologies. According to the report, the FDA is prepared to clear the […]

Talon Therapeutics Adds Its Name to the Hit Parade (TLON)

It certainly appears that biomedical is the theme for the week in over-the-counter stocks. Today, the stock of Talon Therapeutics (OTC:TLON) popped on to the radar screen after posting a 10% gain for the session on 1.4 million shares.¬† Earlier in the week, InVivo Therapeutics (OTC: NVIV) and Oncosec Medical (OTC: ONCS) surged on volume […]

InVivo Therapeutics Holdings Climbs, Gaining Popularity with the Public (NVIV)

After a month long fall, InVivo Therapeutics (OTC: NVIV) finally turned the corner, rising an impressive 12.8% to $2.38. What is even more impressive about this sudden turnaround is that the company did it amidst a complete market drop. Other penny stock success stories such as Great Wall Builders (OTC: GWGB) and OncoSec Medical (OTC: […]